-
Vaccine is 94.5 per cent effective in preventing COVID-19: Moderna
expresspharma
November 17, 2020
Moderna said its experimental vaccine was 94.5 per cent effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second US company to report results that far exceed expectations.
-
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
prnasia
November 16, 2020
Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate.
-
Novavax Expands Facility to Support Global Vaccine Development
contractpharma
November 11, 2020
Expands campus with two properties to support vaccine research and development, manufacturing, business operations.
-
Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements
expresspharma
November 11, 2020
Rajarshi Datta, Country Head & General Manager – South Asia, Honeywell Advanced Materials informs there is a growing need for new packaging technologies that allow the pharma industry to launch drugs to market faster while reducing operational costs and..
-
Indian scientists working on effective vaccines against COVID-19 and HIV: IISC
expresspharma
November 11, 2020
The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences.
-
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
prnasia
November 10, 2020
The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. A Basel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal.
-
Scientists develop COVID-19 vaccine candidate that generates very high neutralising antibodies
expresspharma
November 06, 2020
The study finds that the nanoparticle vaccine generates ten times more protective antibodies in mice, even at a six-fold lower vaccine dose, and also shows a strong B-cell immune response after administration.
-
NPPA fixes retail price of new-gen rabies vaccine from Cadila Pharma at Rs 681.44
expresspharma
November 05, 2020
The company has not yet disclosed the official launch of the three-dose vaccine.
-
UK regulator initiates rolling review of AstraZeneca’s vaccine for Covid-19
pharmaceutical-technology
November 04, 2020
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has initiated the accelerated rolling review of AstraZeneca’s potential vaccine to treat Covid-19.
-
DOD Awards Ology Vaccine Manufacturing Contract
contractpharma
October 29, 2020
CDMO to manufacture and test novel live attenuated tularemia vaccine candidate.